Global Rabies Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Rabies Vaccine market size was valued at USD 958 million in 2023 and is forecast to a readjusted size of USD 1246.1 million by 2030 with a CAGR of 3.8% during review period.
Rabies vaccine is an active immunizing agent used to prevent infection caused by the rabies virus. The vaccine works by causing your body to produce its own protection (antibodies) against the rabies virus.
Global Rabies Vaccine key players include Chengda, Changsheng, Prcmise, VACN, etc. Global top four manufacturers hold a share about 70%.
China is the largest market, with a share about 85%, followed by Europe, and North America, both have a share over 10 percent.
In terms of product, Vero Cell Rabies Vaccine is the largest segment, with a share over 75%. And in terms of application, the largest application is Post-exposure Prophylaxis, followed by Pre-exposure Prophylaxis.
The Global Info Research report includes an overview of the development of the Rabies Vaccine industry chain, the market status of Pre-exposure Prophylaxis (Vero Cell Rabies Vaccine, BHK), Post-exposure Prophylaxis (Vero Cell Rabies Vaccine, BHK), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Rabies Vaccine.
Regionally, the report analyzes the Rabies Vaccine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Rabies Vaccine market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Rabies Vaccine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Rabies Vaccine industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Vero Cell Rabies Vaccine, BHK).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Rabies Vaccine market.
Regional Analysis: The report involves examining the Rabies Vaccine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Rabies Vaccine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Rabies Vaccine:
Company Analysis: Report covers individual Rabies Vaccine manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Rabies Vaccine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Pre-exposure Prophylaxis, Post-exposure Prophylaxis).
Technology Analysis: Report covers specific technologies relevant to Rabies Vaccine. It assesses the current state, advancements, and potential future developments in Rabies Vaccine areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Rabies Vaccine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Rabies Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Rabies Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Rabies Vaccine, with price, sales, revenue and global market share of Rabies Vaccine from 2019 to 2024.
Chapter 3, the Rabies Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Rabies Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Rabies Vaccine market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Rabies Vaccine.
Chapter 14 and 15, to describe Rabies Vaccine sales channel, distributors, customers, research findings and conclusion.
Rabies vaccine is an active immunizing agent used to prevent infection caused by the rabies virus. The vaccine works by causing your body to produce its own protection (antibodies) against the rabies virus.
Global Rabies Vaccine key players include Chengda, Changsheng, Prcmise, VACN, etc. Global top four manufacturers hold a share about 70%.
China is the largest market, with a share about 85%, followed by Europe, and North America, both have a share over 10 percent.
In terms of product, Vero Cell Rabies Vaccine is the largest segment, with a share over 75%. And in terms of application, the largest application is Post-exposure Prophylaxis, followed by Pre-exposure Prophylaxis.
The Global Info Research report includes an overview of the development of the Rabies Vaccine industry chain, the market status of Pre-exposure Prophylaxis (Vero Cell Rabies Vaccine, BHK), Post-exposure Prophylaxis (Vero Cell Rabies Vaccine, BHK), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Rabies Vaccine.
Regionally, the report analyzes the Rabies Vaccine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Rabies Vaccine market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Rabies Vaccine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Rabies Vaccine industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Vero Cell Rabies Vaccine, BHK).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Rabies Vaccine market.
Regional Analysis: The report involves examining the Rabies Vaccine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Rabies Vaccine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Rabies Vaccine:
Company Analysis: Report covers individual Rabies Vaccine manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Rabies Vaccine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Pre-exposure Prophylaxis, Post-exposure Prophylaxis).
Technology Analysis: Report covers specific technologies relevant to Rabies Vaccine. It assesses the current state, advancements, and potential future developments in Rabies Vaccine areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Rabies Vaccine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Rabies Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Vero Cell Rabies Vaccine
- BHK
- Chick Embryo Cell Rabies Vaccine
- Others
- Pre-exposure Prophylaxis
- Post-exposure Prophylaxis
- GSK (Novartis)
- Sanofi-Pasteur
- Chengda
- Yisheng
- Prcmise
- VACN
- Changsheng
- BCHT
- Hissen
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Rabies Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Rabies Vaccine, with price, sales, revenue and global market share of Rabies Vaccine from 2019 to 2024.
Chapter 3, the Rabies Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Rabies Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Rabies Vaccine market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Rabies Vaccine.
Chapter 14 and 15, to describe Rabies Vaccine sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Rabies Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Rabies Vaccine Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Vero Cell Rabies Vaccine
1.3.3 BHK
1.3.4 Chick Embryo Cell Rabies Vaccine
1.3.5 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Rabies Vaccine Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Pre-exposure Prophylaxis
1.4.3 Post-exposure Prophylaxis
1.5 Global Rabies Vaccine Market Size & Forecast
1.5.1 Global Rabies Vaccine Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Rabies Vaccine Sales Quantity (2019-2030)
1.5.3 Global Rabies Vaccine Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 GSK (Novartis)
2.1.1 GSK (Novartis) Details
2.1.2 GSK (Novartis) Major Business
2.1.3 GSK (Novartis) Rabies Vaccine Product and Services
2.1.4 GSK (Novartis) Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 GSK (Novartis) Recent Developments/Updates
2.2 Sanofi-Pasteur
2.2.1 Sanofi-Pasteur Details
2.2.2 Sanofi-Pasteur Major Business
2.2.3 Sanofi-Pasteur Rabies Vaccine Product and Services
2.2.4 Sanofi-Pasteur Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Sanofi-Pasteur Recent Developments/Updates
2.3 Chengda
2.3.1 Chengda Details
2.3.2 Chengda Major Business
2.3.3 Chengda Rabies Vaccine Product and Services
2.3.4 Chengda Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Chengda Recent Developments/Updates
2.4 Yisheng
2.4.1 Yisheng Details
2.4.2 Yisheng Major Business
2.4.3 Yisheng Rabies Vaccine Product and Services
2.4.4 Yisheng Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Yisheng Recent Developments/Updates
2.5 Prcmise
2.5.1 Prcmise Details
2.5.2 Prcmise Major Business
2.5.3 Prcmise Rabies Vaccine Product and Services
2.5.4 Prcmise Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Prcmise Recent Developments/Updates
2.6 VACN
2.6.1 VACN Details
2.6.2 VACN Major Business
2.6.3 VACN Rabies Vaccine Product and Services
2.6.4 VACN Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 VACN Recent Developments/Updates
2.7 Changsheng
2.7.1 Changsheng Details
2.7.2 Changsheng Major Business
2.7.3 Changsheng Rabies Vaccine Product and Services
2.7.4 Changsheng Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Changsheng Recent Developments/Updates
2.8 BCHT
2.8.1 BCHT Details
2.8.2 BCHT Major Business
2.8.3 BCHT Rabies Vaccine Product and Services
2.8.4 BCHT Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 BCHT Recent Developments/Updates
2.9 Hissen
2.9.1 Hissen Details
2.9.2 Hissen Major Business
2.9.3 Hissen Rabies Vaccine Product and Services
2.9.4 Hissen Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Hissen Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: RABIES VACCINE BY MANUFACTURER
3.1 Global Rabies Vaccine Sales Quantity by Manufacturer (2019-2024)
3.2 Global Rabies Vaccine Revenue by Manufacturer (2019-2024)
3.3 Global Rabies Vaccine Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Rabies Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Rabies Vaccine Manufacturer Market Share in 2023
3.4.2 Top 6 Rabies Vaccine Manufacturer Market Share in 2023
3.5 Rabies Vaccine Market: Overall Company Footprint Analysis
3.5.1 Rabies Vaccine Market: Region Footprint
3.5.2 Rabies Vaccine Market: Company Product Type Footprint
3.5.3 Rabies Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Rabies Vaccine Market Size by Region
4.1.1 Global Rabies Vaccine Sales Quantity by Region (2019-2030)
4.1.2 Global Rabies Vaccine Consumption Value by Region (2019-2030)
4.1.3 Global Rabies Vaccine Average Price by Region (2019-2030)
4.2 North America Rabies Vaccine Consumption Value (2019-2030)
4.3 Europe Rabies Vaccine Consumption Value (2019-2030)
4.4 Asia-Pacific Rabies Vaccine Consumption Value (2019-2030)
4.5 South America Rabies Vaccine Consumption Value (2019-2030)
4.6 Middle East and Africa Rabies Vaccine Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Rabies Vaccine Sales Quantity by Type (2019-2030)
5.2 Global Rabies Vaccine Consumption Value by Type (2019-2030)
5.3 Global Rabies Vaccine Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Rabies Vaccine Sales Quantity by Application (2019-2030)
6.2 Global Rabies Vaccine Consumption Value by Application (2019-2030)
6.3 Global Rabies Vaccine Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Rabies Vaccine Sales Quantity by Type (2019-2030)
7.2 North America Rabies Vaccine Sales Quantity by Application (2019-2030)
7.3 North America Rabies Vaccine Market Size by Country
7.3.1 North America Rabies Vaccine Sales Quantity by Country (2019-2030)
7.3.2 North America Rabies Vaccine Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Rabies Vaccine Sales Quantity by Type (2019-2030)
8.2 Europe Rabies Vaccine Sales Quantity by Application (2019-2030)
8.3 Europe Rabies Vaccine Market Size by Country
8.3.1 Europe Rabies Vaccine Sales Quantity by Country (2019-2030)
8.3.2 Europe Rabies Vaccine Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Rabies Vaccine Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Rabies Vaccine Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Rabies Vaccine Market Size by Region
9.3.1 Asia-Pacific Rabies Vaccine Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Rabies Vaccine Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Rabies Vaccine Sales Quantity by Type (2019-2030)
10.2 South America Rabies Vaccine Sales Quantity by Application (2019-2030)
10.3 South America Rabies Vaccine Market Size by Country
10.3.1 South America Rabies Vaccine Sales Quantity by Country (2019-2030)
10.3.2 South America Rabies Vaccine Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Rabies Vaccine Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Rabies Vaccine Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Rabies Vaccine Market Size by Country
11.3.1 Middle East & Africa Rabies Vaccine Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Rabies Vaccine Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Rabies Vaccine Market Drivers
12.2 Rabies Vaccine Market Restraints
12.3 Rabies Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Rabies Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Rabies Vaccine
13.3 Rabies Vaccine Production Process
13.4 Rabies Vaccine Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Rabies Vaccine Typical Distributors
14.3 Rabies Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Rabies Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Rabies Vaccine Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Vero Cell Rabies Vaccine
1.3.3 BHK
1.3.4 Chick Embryo Cell Rabies Vaccine
1.3.5 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Rabies Vaccine Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Pre-exposure Prophylaxis
1.4.3 Post-exposure Prophylaxis
1.5 Global Rabies Vaccine Market Size & Forecast
1.5.1 Global Rabies Vaccine Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Rabies Vaccine Sales Quantity (2019-2030)
1.5.3 Global Rabies Vaccine Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 GSK (Novartis)
2.1.1 GSK (Novartis) Details
2.1.2 GSK (Novartis) Major Business
2.1.3 GSK (Novartis) Rabies Vaccine Product and Services
2.1.4 GSK (Novartis) Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 GSK (Novartis) Recent Developments/Updates
2.2 Sanofi-Pasteur
2.2.1 Sanofi-Pasteur Details
2.2.2 Sanofi-Pasteur Major Business
2.2.3 Sanofi-Pasteur Rabies Vaccine Product and Services
2.2.4 Sanofi-Pasteur Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Sanofi-Pasteur Recent Developments/Updates
2.3 Chengda
2.3.1 Chengda Details
2.3.2 Chengda Major Business
2.3.3 Chengda Rabies Vaccine Product and Services
2.3.4 Chengda Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Chengda Recent Developments/Updates
2.4 Yisheng
2.4.1 Yisheng Details
2.4.2 Yisheng Major Business
2.4.3 Yisheng Rabies Vaccine Product and Services
2.4.4 Yisheng Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Yisheng Recent Developments/Updates
2.5 Prcmise
2.5.1 Prcmise Details
2.5.2 Prcmise Major Business
2.5.3 Prcmise Rabies Vaccine Product and Services
2.5.4 Prcmise Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Prcmise Recent Developments/Updates
2.6 VACN
2.6.1 VACN Details
2.6.2 VACN Major Business
2.6.3 VACN Rabies Vaccine Product and Services
2.6.4 VACN Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 VACN Recent Developments/Updates
2.7 Changsheng
2.7.1 Changsheng Details
2.7.2 Changsheng Major Business
2.7.3 Changsheng Rabies Vaccine Product and Services
2.7.4 Changsheng Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Changsheng Recent Developments/Updates
2.8 BCHT
2.8.1 BCHT Details
2.8.2 BCHT Major Business
2.8.3 BCHT Rabies Vaccine Product and Services
2.8.4 BCHT Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 BCHT Recent Developments/Updates
2.9 Hissen
2.9.1 Hissen Details
2.9.2 Hissen Major Business
2.9.3 Hissen Rabies Vaccine Product and Services
2.9.4 Hissen Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Hissen Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: RABIES VACCINE BY MANUFACTURER
3.1 Global Rabies Vaccine Sales Quantity by Manufacturer (2019-2024)
3.2 Global Rabies Vaccine Revenue by Manufacturer (2019-2024)
3.3 Global Rabies Vaccine Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Rabies Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Rabies Vaccine Manufacturer Market Share in 2023
3.4.2 Top 6 Rabies Vaccine Manufacturer Market Share in 2023
3.5 Rabies Vaccine Market: Overall Company Footprint Analysis
3.5.1 Rabies Vaccine Market: Region Footprint
3.5.2 Rabies Vaccine Market: Company Product Type Footprint
3.5.3 Rabies Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Rabies Vaccine Market Size by Region
4.1.1 Global Rabies Vaccine Sales Quantity by Region (2019-2030)
4.1.2 Global Rabies Vaccine Consumption Value by Region (2019-2030)
4.1.3 Global Rabies Vaccine Average Price by Region (2019-2030)
4.2 North America Rabies Vaccine Consumption Value (2019-2030)
4.3 Europe Rabies Vaccine Consumption Value (2019-2030)
4.4 Asia-Pacific Rabies Vaccine Consumption Value (2019-2030)
4.5 South America Rabies Vaccine Consumption Value (2019-2030)
4.6 Middle East and Africa Rabies Vaccine Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Rabies Vaccine Sales Quantity by Type (2019-2030)
5.2 Global Rabies Vaccine Consumption Value by Type (2019-2030)
5.3 Global Rabies Vaccine Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Rabies Vaccine Sales Quantity by Application (2019-2030)
6.2 Global Rabies Vaccine Consumption Value by Application (2019-2030)
6.3 Global Rabies Vaccine Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Rabies Vaccine Sales Quantity by Type (2019-2030)
7.2 North America Rabies Vaccine Sales Quantity by Application (2019-2030)
7.3 North America Rabies Vaccine Market Size by Country
7.3.1 North America Rabies Vaccine Sales Quantity by Country (2019-2030)
7.3.2 North America Rabies Vaccine Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Rabies Vaccine Sales Quantity by Type (2019-2030)
8.2 Europe Rabies Vaccine Sales Quantity by Application (2019-2030)
8.3 Europe Rabies Vaccine Market Size by Country
8.3.1 Europe Rabies Vaccine Sales Quantity by Country (2019-2030)
8.3.2 Europe Rabies Vaccine Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Rabies Vaccine Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Rabies Vaccine Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Rabies Vaccine Market Size by Region
9.3.1 Asia-Pacific Rabies Vaccine Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Rabies Vaccine Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Rabies Vaccine Sales Quantity by Type (2019-2030)
10.2 South America Rabies Vaccine Sales Quantity by Application (2019-2030)
10.3 South America Rabies Vaccine Market Size by Country
10.3.1 South America Rabies Vaccine Sales Quantity by Country (2019-2030)
10.3.2 South America Rabies Vaccine Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Rabies Vaccine Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Rabies Vaccine Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Rabies Vaccine Market Size by Country
11.3.1 Middle East & Africa Rabies Vaccine Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Rabies Vaccine Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Rabies Vaccine Market Drivers
12.2 Rabies Vaccine Market Restraints
12.3 Rabies Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Rabies Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Rabies Vaccine
13.3 Rabies Vaccine Production Process
13.4 Rabies Vaccine Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Rabies Vaccine Typical Distributors
14.3 Rabies Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Rabies Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Rabies Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. GSK (Novartis) Basic Information, Manufacturing Base and Competitors
Table 4. GSK (Novartis) Major Business
Table 5. GSK (Novartis) Rabies Vaccine Product and Services
Table 6. GSK (Novartis) Rabies Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. GSK (Novartis) Recent Developments/Updates
Table 8. Sanofi-Pasteur Basic Information, Manufacturing Base and Competitors
Table 9. Sanofi-Pasteur Major Business
Table 10. Sanofi-Pasteur Rabies Vaccine Product and Services
Table 11. Sanofi-Pasteur Rabies Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Sanofi-Pasteur Recent Developments/Updates
Table 13. Chengda Basic Information, Manufacturing Base and Competitors
Table 14. Chengda Major Business
Table 15. Chengda Rabies Vaccine Product and Services
Table 16. Chengda Rabies Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Chengda Recent Developments/Updates
Table 18. Yisheng Basic Information, Manufacturing Base and Competitors
Table 19. Yisheng Major Business
Table 20. Yisheng Rabies Vaccine Product and Services
Table 21. Yisheng Rabies Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Yisheng Recent Developments/Updates
Table 23. Prcmise Basic Information, Manufacturing Base and Competitors
Table 24. Prcmise Major Business
Table 25. Prcmise Rabies Vaccine Product and Services
Table 26. Prcmise Rabies Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Prcmise Recent Developments/Updates
Table 28. VACN Basic Information, Manufacturing Base and Competitors
Table 29. VACN Major Business
Table 30. VACN Rabies Vaccine Product and Services
Table 31. VACN Rabies Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. VACN Recent Developments/Updates
Table 33. Changsheng Basic Information, Manufacturing Base and Competitors
Table 34. Changsheng Major Business
Table 35. Changsheng Rabies Vaccine Product and Services
Table 36. Changsheng Rabies Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Changsheng Recent Developments/Updates
Table 38. BCHT Basic Information, Manufacturing Base and Competitors
Table 39. BCHT Major Business
Table 40. BCHT Rabies Vaccine Product and Services
Table 41. BCHT Rabies Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. BCHT Recent Developments/Updates
Table 43. Hissen Basic Information, Manufacturing Base and Competitors
Table 44. Hissen Major Business
Table 45. Hissen Rabies Vaccine Product and Services
Table 46. Hissen Rabies Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Hissen Recent Developments/Updates
Table 48. Global Rabies Vaccine Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 49. Global Rabies Vaccine Revenue by Manufacturer (2019-2024) & (USD Million)
Table 50. Global Rabies Vaccine Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 51. Market Position of Manufacturers in Rabies Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 52. Head Office and Rabies Vaccine Production Site of Key Manufacturer
Table 53. Rabies Vaccine Market: Company Product Type Footprint
Table 54. Rabies Vaccine Market: Company Product Application Footprint
Table 55. Rabies Vaccine New Market Entrants and Barriers to Market Entry
Table 56. Rabies Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 57. Global Rabies Vaccine Sales Quantity by Region (2019-2024) & (K Units)
Table 58. Global Rabies Vaccine Sales Quantity by Region (2025-2030) & (K Units)
Table 59. Global Rabies Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 60. Global Rabies Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 61. Global Rabies Vaccine Average Price by Region (2019-2024) & (USD/Unit)
Table 62. Global Rabies Vaccine Average Price by Region (2025-2030) & (USD/Unit)
Table 63. Global Rabies Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 64. Global Rabies Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 65. Global Rabies Vaccine Consumption Value by Type (2019-2024) & (USD Million)
Table 66. Global Rabies Vaccine Consumption Value by Type (2025-2030) & (USD Million)
Table 67. Global Rabies Vaccine Average Price by Type (2019-2024) & (USD/Unit)
Table 68. Global Rabies Vaccine Average Price by Type (2025-2030) & (USD/Unit)
Table 69. Global Rabies Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 70. Global Rabies Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 71. Global Rabies Vaccine Consumption Value by Application (2019-2024) & (USD Million)
Table 72. Global Rabies Vaccine Consumption Value by Application (2025-2030) & (USD Million)
Table 73. Global Rabies Vaccine Average Price by Application (2019-2024) & (USD/Unit)
Table 74. Global Rabies Vaccine Average Price by Application (2025-2030) & (USD/Unit)
Table 75. North America Rabies Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 76. North America Rabies Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 77. North America Rabies Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 78. North America Rabies Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 79. North America Rabies Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 80. North America Rabies Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 81. North America Rabies Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 82. North America Rabies Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 83. Europe Rabies Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 84. Europe Rabies Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 85. Europe Rabies Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 86. Europe Rabies Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 87. Europe Rabies Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 88. Europe Rabies Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 89. Europe Rabies Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 90. Europe Rabies Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 91. Asia-Pacific Rabies Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 92. Asia-Pacific Rabies Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 93. Asia-Pacific Rabies Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 94. Asia-Pacific Rabies Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 95. Asia-Pacific Rabies Vaccine Sales Quantity by Region (2019-2024) & (K Units)
Table 96. Asia-Pacific Rabies Vaccine Sales Quantity by Region (2025-2030) & (K Units)
Table 97. Asia-Pacific Rabies Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 98. Asia-Pacific Rabies Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 99. South America Rabies Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 100. South America Rabies Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 101. South America Rabies Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 102. South America Rabies Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 103. South America Rabies Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 104. South America Rabies Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 105. South America Rabies Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 106. South America Rabies Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 107. Middle East & Africa Rabies Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 108. Middle East & Africa Rabies Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 109. Middle East & Africa Rabies Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 110. Middle East & Africa Rabies Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 111. Middle East & Africa Rabies Vaccine Sales Quantity by Region (2019-2024) & (K Units)
Table 112. Middle East & Africa Rabies Vaccine Sales Quantity by Region (2025-2030) & (K Units)
Table 113. Middle East & Africa Rabies Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 114. Middle East & Africa Rabies Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 115. Rabies Vaccine Raw Material
Table 116. Key Manufacturers of Rabies Vaccine Raw Materials
Table 117. Rabies Vaccine Typical Distributors
Table 118. Rabies Vaccine Typical Customers
Table 1. Global Rabies Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Rabies Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. GSK (Novartis) Basic Information, Manufacturing Base and Competitors
Table 4. GSK (Novartis) Major Business
Table 5. GSK (Novartis) Rabies Vaccine Product and Services
Table 6. GSK (Novartis) Rabies Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. GSK (Novartis) Recent Developments/Updates
Table 8. Sanofi-Pasteur Basic Information, Manufacturing Base and Competitors
Table 9. Sanofi-Pasteur Major Business
Table 10. Sanofi-Pasteur Rabies Vaccine Product and Services
Table 11. Sanofi-Pasteur Rabies Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Sanofi-Pasteur Recent Developments/Updates
Table 13. Chengda Basic Information, Manufacturing Base and Competitors
Table 14. Chengda Major Business
Table 15. Chengda Rabies Vaccine Product and Services
Table 16. Chengda Rabies Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Chengda Recent Developments/Updates
Table 18. Yisheng Basic Information, Manufacturing Base and Competitors
Table 19. Yisheng Major Business
Table 20. Yisheng Rabies Vaccine Product and Services
Table 21. Yisheng Rabies Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Yisheng Recent Developments/Updates
Table 23. Prcmise Basic Information, Manufacturing Base and Competitors
Table 24. Prcmise Major Business
Table 25. Prcmise Rabies Vaccine Product and Services
Table 26. Prcmise Rabies Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Prcmise Recent Developments/Updates
Table 28. VACN Basic Information, Manufacturing Base and Competitors
Table 29. VACN Major Business
Table 30. VACN Rabies Vaccine Product and Services
Table 31. VACN Rabies Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. VACN Recent Developments/Updates
Table 33. Changsheng Basic Information, Manufacturing Base and Competitors
Table 34. Changsheng Major Business
Table 35. Changsheng Rabies Vaccine Product and Services
Table 36. Changsheng Rabies Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Changsheng Recent Developments/Updates
Table 38. BCHT Basic Information, Manufacturing Base and Competitors
Table 39. BCHT Major Business
Table 40. BCHT Rabies Vaccine Product and Services
Table 41. BCHT Rabies Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. BCHT Recent Developments/Updates
Table 43. Hissen Basic Information, Manufacturing Base and Competitors
Table 44. Hissen Major Business
Table 45. Hissen Rabies Vaccine Product and Services
Table 46. Hissen Rabies Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Hissen Recent Developments/Updates
Table 48. Global Rabies Vaccine Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 49. Global Rabies Vaccine Revenue by Manufacturer (2019-2024) & (USD Million)
Table 50. Global Rabies Vaccine Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 51. Market Position of Manufacturers in Rabies Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 52. Head Office and Rabies Vaccine Production Site of Key Manufacturer
Table 53. Rabies Vaccine Market: Company Product Type Footprint
Table 54. Rabies Vaccine Market: Company Product Application Footprint
Table 55. Rabies Vaccine New Market Entrants and Barriers to Market Entry
Table 56. Rabies Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 57. Global Rabies Vaccine Sales Quantity by Region (2019-2024) & (K Units)
Table 58. Global Rabies Vaccine Sales Quantity by Region (2025-2030) & (K Units)
Table 59. Global Rabies Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 60. Global Rabies Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 61. Global Rabies Vaccine Average Price by Region (2019-2024) & (USD/Unit)
Table 62. Global Rabies Vaccine Average Price by Region (2025-2030) & (USD/Unit)
Table 63. Global Rabies Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 64. Global Rabies Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 65. Global Rabies Vaccine Consumption Value by Type (2019-2024) & (USD Million)
Table 66. Global Rabies Vaccine Consumption Value by Type (2025-2030) & (USD Million)
Table 67. Global Rabies Vaccine Average Price by Type (2019-2024) & (USD/Unit)
Table 68. Global Rabies Vaccine Average Price by Type (2025-2030) & (USD/Unit)
Table 69. Global Rabies Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 70. Global Rabies Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 71. Global Rabies Vaccine Consumption Value by Application (2019-2024) & (USD Million)
Table 72. Global Rabies Vaccine Consumption Value by Application (2025-2030) & (USD Million)
Table 73. Global Rabies Vaccine Average Price by Application (2019-2024) & (USD/Unit)
Table 74. Global Rabies Vaccine Average Price by Application (2025-2030) & (USD/Unit)
Table 75. North America Rabies Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 76. North America Rabies Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 77. North America Rabies Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 78. North America Rabies Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 79. North America Rabies Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 80. North America Rabies Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 81. North America Rabies Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 82. North America Rabies Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 83. Europe Rabies Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 84. Europe Rabies Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 85. Europe Rabies Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 86. Europe Rabies Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 87. Europe Rabies Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 88. Europe Rabies Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 89. Europe Rabies Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 90. Europe Rabies Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 91. Asia-Pacific Rabies Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 92. Asia-Pacific Rabies Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 93. Asia-Pacific Rabies Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 94. Asia-Pacific Rabies Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 95. Asia-Pacific Rabies Vaccine Sales Quantity by Region (2019-2024) & (K Units)
Table 96. Asia-Pacific Rabies Vaccine Sales Quantity by Region (2025-2030) & (K Units)
Table 97. Asia-Pacific Rabies Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 98. Asia-Pacific Rabies Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 99. South America Rabies Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 100. South America Rabies Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 101. South America Rabies Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 102. South America Rabies Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 103. South America Rabies Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 104. South America Rabies Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 105. South America Rabies Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 106. South America Rabies Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 107. Middle East & Africa Rabies Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 108. Middle East & Africa Rabies Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 109. Middle East & Africa Rabies Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 110. Middle East & Africa Rabies Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 111. Middle East & Africa Rabies Vaccine Sales Quantity by Region (2019-2024) & (K Units)
Table 112. Middle East & Africa Rabies Vaccine Sales Quantity by Region (2025-2030) & (K Units)
Table 113. Middle East & Africa Rabies Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 114. Middle East & Africa Rabies Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 115. Rabies Vaccine Raw Material
Table 116. Key Manufacturers of Rabies Vaccine Raw Materials
Table 117. Rabies Vaccine Typical Distributors
Table 118. Rabies Vaccine Typical Customers
LIST OF FIGURES
Figure 1. Rabies Vaccine Picture
Figure 2. Global Rabies Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Rabies Vaccine Consumption Value Market Share by Type in 2023
Figure 4. Vero Cell Rabies Vaccine Examples
Figure 5. BHK Examples
Figure 6. Chick Embryo Cell Rabies Vaccine Examples
Figure 7. Others Examples
Figure 8. Global Rabies Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 9. Global Rabies Vaccine Consumption Value Market Share by Application in 2023
Figure 10. Pre-exposure Prophylaxis Examples
Figure 11. Post-exposure Prophylaxis Examples
Figure 12. Global Rabies Vaccine Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global Rabies Vaccine Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global Rabies Vaccine Sales Quantity (2019-2030) & (K Units)
Figure 15. Global Rabies Vaccine Average Price (2019-2030) & (USD/Unit)
Figure 16. Global Rabies Vaccine Sales Quantity Market Share by Manufacturer in 2023
Figure 17. Global Rabies Vaccine Consumption Value Market Share by Manufacturer in 2023
Figure 18. Producer Shipments of Rabies Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 19. Top 3 Rabies Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Top 6 Rabies Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 21. Global Rabies Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 22. Global Rabies Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 23. North America Rabies Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 24. Europe Rabies Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 25. Asia-Pacific Rabies Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 26. South America Rabies Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 27. Middle East & Africa Rabies Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 28. Global Rabies Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 29. Global Rabies Vaccine Consumption Value Market Share by Type (2019-2030)
Figure 30. Global Rabies Vaccine Average Price by Type (2019-2030) & (USD/Unit)
Figure 31. Global Rabies Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 32. Global Rabies Vaccine Consumption Value Market Share by Application (2019-2030)
Figure 33. Global Rabies Vaccine Average Price by Application (2019-2030) & (USD/Unit)
Figure 34. North America Rabies Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 35. North America Rabies Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 36. North America Rabies Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 37. North America Rabies Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 38. United States Rabies Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Canada Rabies Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Mexico Rabies Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Europe Rabies Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 42. Europe Rabies Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 43. Europe Rabies Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 44. Europe Rabies Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 45. Germany Rabies Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. France Rabies Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. United Kingdom Rabies Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Russia Rabies Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Italy Rabies Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Asia-Pacific Rabies Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 51. Asia-Pacific Rabies Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 52. Asia-Pacific Rabies Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 53. Asia-Pacific Rabies Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 54. China Rabies Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Japan Rabies Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Korea Rabies Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. India Rabies Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Southeast Asia Rabies Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Australia Rabies Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. South America Rabies Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 61. South America Rabies Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 62. South America Rabies Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 63. South America Rabies Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 64. Brazil Rabies Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Argentina Rabies Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Middle East & Africa Rabies Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 67. Middle East & Africa Rabies Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 68. Middle East & Africa Rabies Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 69. Middle East & Africa Rabies Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 70. Turkey Rabies Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Egypt Rabies Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Saudi Arabia Rabies Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. South Africa Rabies Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Rabies Vaccine Market Drivers
Figure 75. Rabies Vaccine Market Restraints
Figure 76. Rabies Vaccine Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Rabies Vaccine in 2023
Figure 79. Manufacturing Process Analysis of Rabies Vaccine
Figure 80. Rabies Vaccine Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
Figure 1. Rabies Vaccine Picture
Figure 2. Global Rabies Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Rabies Vaccine Consumption Value Market Share by Type in 2023
Figure 4. Vero Cell Rabies Vaccine Examples
Figure 5. BHK Examples
Figure 6. Chick Embryo Cell Rabies Vaccine Examples
Figure 7. Others Examples
Figure 8. Global Rabies Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 9. Global Rabies Vaccine Consumption Value Market Share by Application in 2023
Figure 10. Pre-exposure Prophylaxis Examples
Figure 11. Post-exposure Prophylaxis Examples
Figure 12. Global Rabies Vaccine Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global Rabies Vaccine Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global Rabies Vaccine Sales Quantity (2019-2030) & (K Units)
Figure 15. Global Rabies Vaccine Average Price (2019-2030) & (USD/Unit)
Figure 16. Global Rabies Vaccine Sales Quantity Market Share by Manufacturer in 2023
Figure 17. Global Rabies Vaccine Consumption Value Market Share by Manufacturer in 2023
Figure 18. Producer Shipments of Rabies Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 19. Top 3 Rabies Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Top 6 Rabies Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 21. Global Rabies Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 22. Global Rabies Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 23. North America Rabies Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 24. Europe Rabies Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 25. Asia-Pacific Rabies Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 26. South America Rabies Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 27. Middle East & Africa Rabies Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 28. Global Rabies Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 29. Global Rabies Vaccine Consumption Value Market Share by Type (2019-2030)
Figure 30. Global Rabies Vaccine Average Price by Type (2019-2030) & (USD/Unit)
Figure 31. Global Rabies Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 32. Global Rabies Vaccine Consumption Value Market Share by Application (2019-2030)
Figure 33. Global Rabies Vaccine Average Price by Application (2019-2030) & (USD/Unit)
Figure 34. North America Rabies Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 35. North America Rabies Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 36. North America Rabies Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 37. North America Rabies Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 38. United States Rabies Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Canada Rabies Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Mexico Rabies Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Europe Rabies Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 42. Europe Rabies Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 43. Europe Rabies Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 44. Europe Rabies Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 45. Germany Rabies Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. France Rabies Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. United Kingdom Rabies Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Russia Rabies Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Italy Rabies Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Asia-Pacific Rabies Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 51. Asia-Pacific Rabies Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 52. Asia-Pacific Rabies Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 53. Asia-Pacific Rabies Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 54. China Rabies Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Japan Rabies Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Korea Rabies Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. India Rabies Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Southeast Asia Rabies Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Australia Rabies Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. South America Rabies Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 61. South America Rabies Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 62. South America Rabies Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 63. South America Rabies Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 64. Brazil Rabies Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Argentina Rabies Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Middle East & Africa Rabies Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 67. Middle East & Africa Rabies Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 68. Middle East & Africa Rabies Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 69. Middle East & Africa Rabies Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 70. Turkey Rabies Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Egypt Rabies Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Saudi Arabia Rabies Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. South Africa Rabies Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Rabies Vaccine Market Drivers
Figure 75. Rabies Vaccine Market Restraints
Figure 76. Rabies Vaccine Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Rabies Vaccine in 2023
Figure 79. Manufacturing Process Analysis of Rabies Vaccine
Figure 80. Rabies Vaccine Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
